Bicara Therapeutics (NasdaqGM:BCAX) FY Conference December 02, 2025 04:30 PM ET Speaker1Perfect. Let's get started. Welcome, everybody, to the next session. My name is Kelsey Goodwin. I am one of the analysts here at Piper Sandler. Our next session, we have Bicara. We have the President and COO, Ryan Cohlhepp. Thanks for joining us.Speaker0Thank you.Speaker1Let's start with a quick summary of Bicara, where we stand heading into year-end and 2026.Speaker0Yeah. So for those of you who are not familiar with Bi ...